nafamostat has been researched along with Carotid Stenosis in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sawada, M | 1 |
Yanamoto, H | 1 |
Nagata, I | 1 |
Hashimoto, N | 1 |
Nakahara, I | 1 |
Akiyama, Y | 1 |
Kikuchi, H | 1 |
Macdonald, RL | 1 |
1 other study available for nafamostat and Carotid Stenosis
Article | Year |
---|---|
Prevention of neointimal formation by a serine protease inhibitor, FUT-175, after carotid balloon injury in rats.
Topics: Animals; Benzamidines; Carotid Stenosis; Guanidines; Male; Rats; Rats, Sprague-Dawley; Serine Protei | 1999 |